Literature DB >> 1573273

Interactions of bacterial lipopolysaccharide with microtubule proteins.

A Ding1, E Sanchez, M Tancinco, C Nathan.   

Abstract

Bacterial LPS is a potent stimulator of immune cells, but its mechanisms are unknown. A possible role for microtubules in LPS actions has been indicated by previous findings that the microtubule-active agent, taxol, can mimic some effects of LPS in macrophages from normal strains of mice, but not from genetically LPS-hyporesponsive strains. In this report we demonstrate that isolated microtubules from mouse brain can bind LPS in vitro. LPS and tubulin coeluted through a gel filtration column, and LPS was cross-linked to microtubule proteins with an iodinatable, photoreactive agent, sulfosuccinimidyl 2-(p-azidosalicylamido) ethyl-1,3'-dithiopropionate. beta-Tubulin and microtubule-associated protein-2 (MAP), a predominant MAP in the brain, bound LPS specifically. Cross-linking was inhibited by an excess of unlabeled LPS or partially by unlabeled lipid A, but not by 2 M NaCl. Under the same conditions, neither myosin nor soybean trypsin inhibitor was labeled by the photoaffinity LPS probe, nor did these proteins compete for binding of LPS to beta-tubulin. These findings support the hypothesis that the microtubule network could be an intracellular target for LPS, and suggest further that a beta-tubulin-associated MAP could have an important role in LPS actions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1573273

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Desquamation of urinary bladder epithelial cells.

Authors:  K Jezernik
Journal:  Pflugers Arch       Date:  1996       Impact factor: 3.657

2.  Biochemical and electron microscopy analysis of the endotoxin binding to microtubules in vitro.

Authors:  C Risco; J E Domínguez; M A Bosch; J L Carrascosa
Journal:  Mol Cell Biochem       Date:  1993-04-07       Impact factor: 3.396

3.  Quantitative aspects of lipopolysaccharide and cytokine requirements to generate nitric oxide in macrophages from LPS-hyporesponsive (Lps(d)) C3H/HeJ mice.

Authors:  E Kmonícková; Z Zídek
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

4.  Microtubule-disrupting agents inhibit nitric oxide production in murine peritoneal macrophages stimulated with lipopolysaccharide or paclitaxel (Taxol).

Authors:  T Kirikae; F Kirikae; Y Oghiso; M Nakano
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

5.  Release of lipopolysaccharide from intracellular compartments containing Salmonella typhimurium to vesicles of the host epithelial cell.

Authors:  F Garcia-del Portillo; M A Stein; B B Finlay
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

6.  CD14 is not involved in Rhodobacter sphaeroides diphosphoryl lipid A inhibition of tumor necrosis factor alpha and nitric oxide induction by taxol in murine macrophages.

Authors:  F Kirikae; T Kirikae; N Qureshi; K Takayama; D C Morrison; M Nakano
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

7.  Association of mitogen-activated protein kinases with microtubules in mouse macrophages.

Authors:  A Ding; B Chen; M Fuortes; E Blum
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

8.  Treatment of experimental mouse bladder tumour by LPS-induced epithelial cell shedding.

Authors:  O Nativ; O Medalia; Y Mor; I Shajrawi; E Sabo; M Aronson
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

9.  Intracellular recognition of lipopolysaccharide by toll-like receptor 4 in intestinal epithelial cells.

Authors:  Mathias W Hornef; Birgitta Henriques Normark; Alain Vandewalle; Staffan Normark
Journal:  J Exp Med       Date:  2003-10-20       Impact factor: 14.307

10.  Lipopolysaccharide antagonists block taxol-induced signaling in murine macrophages.

Authors:  C L Manthey; N Qureshi; P L Stütz; S N Vogel
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.